Advertisement
Screener

Neogen Corporation (NEOG) Material Contracts

Neogen Corporation Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-07-30: Form 10-K; Exhibit 10.30; Description Transition and Separation Agreement between Neogen Corporation and Amy Rocklin dated March 25, 2026 (1).
  • 2026-07-30: Form 10-K; Exhibit 10.25; Description Form of Severance Letter Agreement entered into with executive officers (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed October 31, 2023). (1).
  • 2026-07-30: Form 10-K; Exhibit 10.17; Description Form of Restricted Share Unit Award Agreement between Neogen Corporation and certain executive officers (starting October 2025) (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-K filed January 8,2026). (1).
  • 2026-07-30: Form 10-K; Exhibit 10.16; Description Neogen Corporation 2023 Omnibus Incentive Plan (incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed September 18, 2023). (1).
FiledFormExhibitDescription
2026-07-3010-K10.30Transition and Separation Agreement between Neogen Corporation and Amy Rocklin dated March 25, 2026 (1)
2026-07-3010-K10.25Form of Severance Letter Agreement entered into with executive officers (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed October 31, 2023). (1)
2026-07-3010-K10.17Form of Restricted Share Unit Award Agreement between Neogen Corporation and certain executive officers (starting October 2025) (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-K filed January 8,2026). (1)
2026-07-3010-K10.16Neogen Corporation 2023 Omnibus Incentive Plan (incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed September 18, 2023). (1)
2026-01-0810-Q10.8Form of Restricted Share Unit Award Agreement between Neogen Corporation and independent directors (starting October 2025) (1)
2026-01-0810-Q10.7Form of Stock Option Award Agreement between Neogen Corporation and independent directors (starting October 2025) (1)
2026-01-0810-Q10.6Form of Restricted Share Unit Award Agreement between Neogen Corporation and certain executive officers (for inducement grants) (1)
2026-01-0810-Q10.5Form of Stock Option Award Agreement between Neogen Corporation and certain executive officers (for inducement grants) (1)
2026-01-0810-Q10.4Form of Performance Share Unit Award Agreement between Neogen Corporation and certain executive officers (for inducement grants) (1)
2026-01-0810-Q10.3Form of Restricted Share Unit Award Agreement between Neogen Corporation and certain executive officers (starting October 2025) (1)
2026-01-0810-Q10.2Form of Stock Option Award Agreement between Neogen Corporation and certain executive officers (starting October 2025) (1)
2026-01-0810-Q10.1Form of Performance Share Unit Award Agreement between Neogen Corporation and certain executive officers (starting October 2025)(1)
2025-10-308-K10.1Offer Letter between Neogen Corporation and Bryan Riggsbee dated October 24, 2025.
2025-10-0910-Q10.5Stock Option Award Agreement between Neogen Corporation and Mikhael Nassif dated August 15, 2025
2025-10-0910-Q10.4Performance Share Unit Award Agreement between Neogen Corporation and Mikhael Nassif dated August 15, 2025
2025-10-0910-Q10.3Stock Option Award Agreement between Neogen Corporation and Mikhael Nassif dated August 15, 2025
2025-10-0910-Q10.2Restricted Stock Unit Award Agreement between Neogen Corporation and Mikhael Nassif dated August 15, 2025
2025-10-0910-Q10.1Form of Performance Share Unit Award Agreement between Neogen Corporation and certain executive officers
2025-07-3010-K10.19Option Agreement between Neogen Corporation and David H. Naemura, dated October 26, 2023 (incorporated by reference to Exhibit 10.17 to the Annual Report on Form 10-K filed July 30,2024). (1)
2025-07-3010-K10.17Form of Management Restricted Share Unit Award Agreement (incorporated by reference to Exhibit 10.17 to the Annual Report on Form 10-K filed July 30,2024). (1)
2025-07-3010-K10.16Form of Management Stock Option Award Agreement (incorporated by reference to Exhibit 10.16 to the Annual Report on Form 10-K filed July 30, 2024). (1).
2025-07-248-K10.1Offer Letter dated June 30, 2025
2025-04-098-K10.1Transition Agreement
2025-04-078-K10.1Refinancing Agreement
2024-07-3010-K10.19Option Agreement between Neogen Corporation and David H. Naemura, dated October 26, 2023. (1)
2024-07-3010-K10.17Form of Management Restricted Share Unit Award Agreement. (1)
2024-07-3010-K10.16Form of Management Stock Option Award Agreement. (1)
2023-10-318-K10.1Form of Severance Letter Agreement.
2022-09-018-K10.8Real Estate License Agreement, dated as of September 1, 2022, by and among certain subsidiaries of Neogen Corporation, 3M Company and certain of its subsidiaries.*
2022-09-018-K10.7Clean-Trace(TM) Distribution Agreement, dated as of September 1, 2022, by and between 3M Company and Garden SpinCo Corporation.*†
2022-09-018-K10.6Transition Contract Manufacturing Agreement, dated as of September 1, 2022, by and among 3M Company, Garden SpinCo Corporation and Neogen Corporation.*†
2022-09-018-K10.5Transition Distribution Services Agreement, dated as of September 1, 2022, by and among 3M Company, Garden SpinCo Corporation and Neogen Corporation.*†
2022-09-018-K10.4Transition Services Agreement, dated as of September 1, 2022, by and among 3M Company, Garden SpinCo Corporation and Neogen Corporation.*†
2022-09-018-K10.3Trademark Transitional License Agreement, dated as of September 1, 2022, by and among 3M Company, 3M Innovative Properties Company, Neogen Corporation and Garden SpinCo Corporation.*†
2022-09-018-K10.2Intellectual Property Cross-License Agreement, dated as of September 1, 2022, by and between 3M Company and Garden SpinCo Corporation.*
2022-09-018-K10.1Tax Matters Agreement, dated as of September 1, 2022, by and among 3M Company, Garden SpinCo Corporation and Neogen Corporation.*
2021-12-158-K10.1Employee Matters Agreement, dated as of December 13, 2021, by and among Neogen Corporation, Garden SpinCo Corporation and 3M Company
2020-12-178-K10.ASecond Amendment to Amended and Restated Credit Agreement dated as of November 30, 2020 between Registrant and JPMorgan Chase Bank, N.A.
2018-12-068-K10.AAmended and Restated Credit Agreement dated as of November 30, 2018 between registrant and JPMorgan Chase Bank, N.A.
2016-12-068-K10.AAMENDED AND RESTATED CREDIT AGREEMENT
2014-07-3010-K10.4Fourth Amendment to Credit Agreement dated May 30, 2014 between Registrant and JPMorgan Chase N.A.
2014-07-3010-K10.3Line of Credit Note (Facility A) dated May 30, 2014 between Registrant and JPMorgan Chase N.A.
2012-09-2810-Q10.2Line of Credit Note between Registrant and JPMorgan Chase dated August 31, 2012.
2012-09-2810-Q10.1Third Amendment to Credit Agreement between Registrant and JPMorgan Chase dated August 31, 2012.
2012-07-3010-K10.6SUMMARY OF DIRECTOR COMPENSATION
2012-07-3010-K10.4SECOND AMENDMENT TO CREDIT AGREEMENT
2012-07-3010-K10.3.ALINE OF CREDIT NOTE
2012-07-3010-K10.3.BLINE OF CREDIT NOTE
2011-09-098-K10.ASECOND AMENDMENT TO CREDIT AGREEMENT
2011-09-098-K10.BLINE OF CREDIT NOTE (FACILITY A)
2011-09-098-K10.CLINE OF CREDIT NOTE (FACILITY B)
2010-08-1610-K10.13STOCK PURCHASE AGREEMENT
2010-08-1610-K10.12CREDIT AGREEMENT
2010-08-1610-K10.11LINE OF CREDIT NOTE
2010-01-0510-Q10.44SECOND AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE
2010-01-0510-Q10.43AMENDED LOAN AGREEMENT AND PROMISSORY NOTE
2009-01-0910-Q10.42BANK OF AMERICA DECEMBER 26, 2008 AMENDED LOAN AGREEMENT
2009-01-0910-Q10.41BANK OF AMERICA DECEMBER 26, 2008 AMENDED PROMISSORY NOTE

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93